Interplay of Atherogenic Particle Number and Particle Size and the Risk of Coronary Heart Disease.

导出 OA

翻译打印收藏纠错

作者： Karol M,Pencina ^[1] ; Michael J,Pencina ^[2] ; Patrick R,Lawler ^[3] ; James C,Engert ^[4] ; Line,Dufresne ^[5] ; Paul M,Ridker ^[6] ; George,Thanassoulis ^[5] ; Samia,Mora ^[7] ; Allan D,Sniderman ^[5]

作者单位： Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. ^[1] North Carolina Department of Laboratory Medicine, Duke University School of Medicine, Biostatistics and Bioinformatics, DCRI, Durham, NC 27614, USA. ^[2] Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, Ontario M5G 2C4, Canada. ^[3] Research Institute of the McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada. ^[4] Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Montreal, Quebec H4A 3J1, Canada. ^[5] Department of Medicine, Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA. ^[6] Center for Lipid Metabolomics, Division of Preventive Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA. ^[7]

关键词 LDL-C/apoB apoB coronary heart disease risk